Wedge Industrial Co.,Ltd. (SHE:000534)
China
· Delayed Price · Currency is CNY 45.36
+4.12 (9.99%)
Mar 9, 2026, 3:04 PM CST
Wedge Industrial Revenue
Wedge Industrial had revenue of 315.17M CNY in the quarter ending September 30, 2025, with 14.79% growth. This brings the company's revenue in the last twelve months to 1.24B, up 20.40% year-over-year. In the year 2024, Wedge Industrial had annual revenue of 1.08B with 9.93% growth.
Revenue (ttm)
1.24B
Revenue Growth
+20.40%
P/S Ratio
17.61
Revenue / Employee
889.15K
Employees
1,397
Market Cap
21.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08B | 97.43M | 9.93% |
| Dec 31, 2023 | 981.44M | 187.60M | 23.63% |
| Jan 1, 2023 | 793.84M | 137.59M | 20.97% |
| Jan 1, 2022 | 656.26M | 103.69M | 18.77% |
| Dec 31, 2020 | 552.56M | 3.83M | 0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 10.50B |
| Joincare Pharmaceutical Group Industry | 15.20B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 1.25B |
| China Resources Double-Crane Pharmaceutical | 10.95B |
| Walvax Biotechnology | 2.40B |
| Tasly Pharmaceutical Group | 8.24B |
| Betta Pharmaceuticals | 3.26B |
| Jilin Aodong Pharmaceutical Group | 2.34B |